Patents provide a company with exclusive rights to their innovation, preventing competitors from copying or selling the same product. This can lead to increased market share and potentially higher revenues. Therefore, the news of Cellectar Biosciences securing four patents is likely to be viewed positively by investors, potentially leading to an increase in the company's stock price in the short term.